scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q3 EPS of ($0.75), $0.45 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $10.02 million versus the consensus estimate of $10.81 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.